150 related articles for article (PubMed ID: 10364203)
1. Ligand-mediated tertiary structure changes of reconstituted P-glycoprotein. A tryptophan fluorescence quenching analysis.
Sonveaux N; Vigano C; Shapiro AB; Ling V; Ruysschaert JM
J Biol Chem; 1999 Jun; 274(25):17649-54. PubMed ID: 10364203
[TBL] [Abstract][Full Text] [Related]
2. Nucleotide-induced conformational changes in the human multidrug resistance protein MRP1 are related to the capacity of chemotherapeutic drugs to accumulate or not in resistant cells.
Manciu L; Chang X; Riordan JR; Buyse F; Ruysschaert JM
FEBS Lett; 2001 Mar; 493(1):31-5. PubMed ID: 11278000
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic fluorescence of the P-glycoprotein multidrug transporter: sensitivity of tryptophan residues to binding of drugs and nucleotides.
Liu R; Siemiarczuk A; Sharom FJ
Biochemistry; 2000 Dec; 39(48):14927-38. PubMed ID: 11101309
[TBL] [Abstract][Full Text] [Related]
4. Secondary and tertiary structure changes of reconstituted P-glycoprotein. A Fourier transform attenuated total reflection infrared spectroscopy analysis.
Sonveaux N; Shapiro AB; Goormaghtigh E; Ling V; Ruysschaert JM
J Biol Chem; 1996 Oct; 271(40):24617-24. PubMed ID: 8798727
[TBL] [Abstract][Full Text] [Related]
5. The effects of anthracycline drugs on the conformational distribution of mouse P-glycoprotein explains their transport rate differences.
Nguyen PH; Sigdel KP; Schaefer KG; Mensah GAK; King GM; Roberts AG
Biochem Pharmacol; 2020 Apr; 174():113813. PubMed ID: 31954717
[TBL] [Abstract][Full Text] [Related]
6. Characterization of an asymmetric occluded state of P-glycoprotein with two bound nucleotides: implications for catalysis.
Siarheyeva A; Liu R; Sharom FJ
J Biol Chem; 2010 Mar; 285(10):7575-86. PubMed ID: 20061384
[TBL] [Abstract][Full Text] [Related]
7. Conformational changes of P-glycoprotein by nucleotide binding.
Wang G; Pincheira R; Zhang M; Zhang JT
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):897-904. PubMed ID: 9396736
[TBL] [Abstract][Full Text] [Related]
8. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
Friche E; Demant EJ; Sehested M; Nissen NI
Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells.
Sharom FJ; Yu X; Lu P; Liu R; Chu JW; Szabó K; Müller M; Hose CD; Monks A; Váradi A; Seprôdi J; Sarkadi B
Biochem Pharmacol; 1999 Aug; 58(4):571-86. PubMed ID: 10413294
[TBL] [Abstract][Full Text] [Related]
10. Reconstitution of purified P-glycoprotein into liposomes.
Naito M; Tsuruo T
J Cancer Res Clin Oncol; 1995; 121(9-10):582-6. PubMed ID: 7559741
[TBL] [Abstract][Full Text] [Related]
11. Iodomycin and iodipine, a structural analogue of azidopine, bind to a common domain in hamster P-glycoprotein.
Demmer A; Andreae S; Thole H; Tümmler B
Eur J Biochem; 1999 Sep; 264(3):800-5. PubMed ID: 10491126
[TBL] [Abstract][Full Text] [Related]
12. Cellular uptake, cytotoxicity, and transport kinetics of anthracyclines in human sensitive and multidrug-resistant K562 cells.
Praet M; Stryckmans P; Ruysschaert JM
Biochem Pharmacol; 1996 May; 51(10):1341-8. PubMed ID: 8787550
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of a tryptophan-less P-glycoprotein: a tool for tryptophan insertion and fluorescence spectroscopy.
Kwan T; Loughrey H; Brault M; Gruenheid S; Urbatsch IL; Senior AE; Gros P
Mol Pharmacol; 2000 Jul; 58(1):37-47. PubMed ID: 10860925
[TBL] [Abstract][Full Text] [Related]
14. Functional reconstitution of P-glycoprotein reveals an apparent near stoichiometric drug transport to ATP hydrolysis.
Eytan GD; Regev R; Assaraf YG
J Biol Chem; 1996 Feb; 271(6):3172-8. PubMed ID: 8621717
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance protein MRP1 reconstituted into lipid vesicles: secondary structure and nucleotide-induced tertiary structure changes.
Manciu L; Chang XB; Riordan JR; Ruysschaert JM
Biochemistry; 2000 Oct; 39(42):13026-33. PubMed ID: 11041868
[TBL] [Abstract][Full Text] [Related]
16. The vinblastine binding site adopts high- and low-affinity conformations during a transport cycle of P-glycoprotein.
Martin C; Higgins CF; Callaghan R
Biochemistry; 2001 Dec; 40(51):15733-42. PubMed ID: 11747450
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
Pascaud C; Garrigos M; Orlowski S
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
[TBL] [Abstract][Full Text] [Related]
18. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation.
Sharom FJ; Lu P; Liu R; Yu X
Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):621-30. PubMed ID: 9677321
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of doxorubicin activity in multidrug-resistant cells by mefloquine.
Fujita R; Ishikawa M; Takayanagi M; Takayanagi Y; Sasaki K
Methods Find Exp Clin Pharmacol; 2000 Jun; 22(5):281-4. PubMed ID: 11031728
[TBL] [Abstract][Full Text] [Related]
20. Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport.
Sharom FJ; Yu X; DiDiodato G; Chu JW
Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):421-8. PubMed ID: 8973548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
